Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02574494 · ClinicalTrials.gov registry record
Does Breastfeeding Lower Blood Pressure in Postpartum Hypertensive Patients
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 40
- Enrollment target
NCT02574494: Completed study, sponsored by Cedars-Sinai Medical Center.
NCT02574494 is a clinical trial that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02574494 has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The primary aim is to establish whether breastfeeding is associated with lowering blood pressure in hypertensive women.
Primary Outcome
A decrease of 15mmHg systolic, 10mmHg diastolic, or a decrease of 10% from baseline will be considered significant.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-12 |
What the finished NCT02574494 record still lists
NCT02574494 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02574494 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02574494 about?
NCT02574494 is a clinical study titled "Does Breastfeeding Lower Blood Pressure in Postpartum Hypertensive Patients". The primary aim is to establish whether breastfeeding is associated with lowering blood pressure in hypertensive women.
What is the current status of trial NCT02574494?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2015-10. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT02574494?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia